|
Erreichen Sie Life Sciences, Inc. (Achv) DCF -Bewertung
CA | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Achieve Life Sciences, Inc. (ACHV) Bundle
Entdecken Sie das wahre Potenzial von Lifes Sciences, Inc. (ACHV) mit unserem DCF-Taschenrechner für professionelle Qualitätsqualität! Passen Sie die wichtigsten Annahmen an, erkunden Sie verschiedene Szenarien und bewerten Sie die Auswirkungen von Änderungen auf die Bewertung der Lebenswissenschaften - alles bequem innerhalb einer Excel -Vorlage.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -16.1 | -14.5 | -32.9 | -40.3 | -26.7 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .3 | .3 | .3 | .2 | .2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -16.4 | -14.7 | -33.2 | -40.6 | -27.0 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 16.7 | 35.9 | 43.0 | 24.8 | 15.5 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .2 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | -2.5 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .9 | .3 | .8 | 1.7 | .6 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -16.1 | -14.7 | -32.9 | -40.1 | -27.0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -15.1 | -15.0 | -32.3 | -36.5 | -30.3 | -.5 | .0 | .0 | .0 | .0 |
| WACC, % | 12.95 | 12.99 | 12.98 | 12.97 | 13.01 | 12.98 | 12.98 | 12.98 | 12.98 | 12.98 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | 1 | |||||||||
| Equity Value | -2 | |||||||||
| Diluted Shares Outstanding, MM | 20 | |||||||||
| Equity Value Per Share | -0.08 |
What You Will Receive
- Comprehensive Financial Model: Achieve Life Sciences’ actual data facilitates accurate DCF valuation.
- Complete Forecasting Flexibility: Modify revenue growth, profit margins, WACC, and other essential parameters.
- Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Adaptable and Reusable: Designed for versatility, allowing for repeated application in detailed forecasting.
Key Features
- 🔍 Real-Life ACHV Financials: Pre-filled historical and projected data for Achieve Life Sciences, Inc. (ACHV).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Achieve Life Sciences’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Achieve Life Sciences’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download: Obtain the pre-built Excel file containing Achieve Life Sciences, Inc.'s (ACHV) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and evaluate results instantly.
- Make Decisions: Leverage the valuation findings to inform your investment approach.
Why Choose This Calculator for Achieve Life Sciences, Inc. (ACHV)?
- User-Friendly Interface: Perfect for both novices and seasoned professionals.
- Customizable Inputs: Adjust variables to tailor your analysis to specific scenarios.
- Real-Time Feedback: Monitor immediate changes to Achieve Life Sciences’ valuation as you modify inputs.
- Preloaded Data: Comes equipped with Achieve Life Sciences’ latest financial information for effortless analysis.
- Relied Upon by Experts: A tool favored by investors and analysts for making strategic decisions.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Achieve Life Sciences, Inc. (ACHV) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Achieve Life Sciences, Inc. (ACHV).
- Consultants: Deliver professional valuation insights for Achieve Life Sciences, Inc. (ACHV) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Achieve Life Sciences, Inc. (ACHV) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios from Achieve Life Sciences, Inc. (ACHV).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Achieve Life Sciences, Inc. (ACHV) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Achieve Life Sciences, Inc. (ACHV).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.